Hoarseness at 16 to 21 days · patients with acute asthma following emergency department discharge
Any ICS showed no clear difference in hoarseness at 16 to 21 days compared with oral corticosteroid (low certainty).
1 finding from 1 review
Intervention not reported
On‐study mortality Death occurring up to 30 days after active study protocol · patients with cancer
The intervention leads to higher on‐study mortality Death occurring up to 30 days after active study… (high certainty).
1 finding from 1 review
Days lost from work Number of people reporting one or more instances of time off work or school · people with asthma
1 finding from 1 review
Mortality (Hospital or 28‐day) · surgical patients
Protocol to increase global blood flow showed no clear difference in mortality (Hospital or 28‐day) compared with control (low certainty).
1 finding from 1 review
Bleeding Number of days with significant bleeding ‐ Low dosage platelet transfusions versus standard dosage platelet transfusions · People with a haematological disorder
1 finding from 1 review
Bleeding: Number of days with significant bleeding ‐ High dosage platelet transfusions versus standard dosage platelet transfusions · People with a haematological disorder
1 finding from 1 review
Bleeding: Number of days on which a significant bleeding event occurred3 · People with a haematological disorder
Prophylactic platelet transfusion showed no clear difference in bleeding: Number of days on which a significant bleeding event… compared with non prophylactic or therapeutic platelet transfusion (low certainty).
1 finding from 1 review
Intervention not reported
Analgesic consumption (day 2) post‐operative · Patients with haemorrhoids
The intervention probably leads to lower analgesic consumption (day 2) post‐operative (moderate certainty).
1 finding from 1 review
28‐Day all‐cause mortality (adult and paediatric patients) · patients with severe sepsis or septic shock
Human recombinant activated protein C showed no clear difference in 28‐Day all‐cause mortality (adult and paediatric patients) compared with placebo (moderate certainty).
1 finding from 1 review
Serious bleeding events in adult and paediatric patients (days 0 to 28) · patients with severe sepsis or septic shock
Human recombinant activated protein C probably leads to higher serious bleeding events in adult and paediatric patients (days 0 to… compared with placebo (moderate certainty).
1 finding from 1 review
Mortality within 5 days · patients with upper gastrointestinal bleeding and liver diseases.
Recombinant human factor VII activated showed no clear difference in mortality within 5 days compared with placebo (moderate certainty).
1 finding from 1 review
Mortality within 42 days · patients with upper gastrointestinal bleeding and liver diseases.
Recombinant human factor VII activated showed no clear difference in mortality within 42 days compared with placebo (moderate certainty).
1 finding from 1 review
Length of time each catheter was in situ · patients with long‐term bladder drainage in adults
1 finding from 1 review
Consistent application of condom by FSWs · sex workers
Social cognitive theory for promotion of condom use showed no clear difference in consistent condom use by FSWs with clients in the past 7‐day compared with no intervention (moderate certainty).
1 finding from 1 review
Clinical failure Number of children with no significant improvement in cough diary scores at two weeks (average of day 13 to 14) · children with primary (intrinsic) tracheomalacia
Human deoxyribonuclease showed no clear difference in clinical failure Number of children with no significant improvement… compared with placebo (low certainty).
1 finding from 1 review
Cough · children with primary (intrinsic) tracheomalacia
1 finding from 1 review
Intervention not reported
Inpatient and 30 day mortality ‐ Colon cancer · Patients with outcomes after colorectal cancer surgery
It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Colon cancer (very low certainty).
1 finding from 1 review
Intervention not reported
Inpatient and 30 day mortality ‐ Rectal cancer · Patients with outcomes after colorectal cancer surgery
The intervention showed no clear difference in inpatient and 30 day mortality ‐ Rectal cancer (low certainty).
1 finding from 1 review
Intervention not reported
Inpatient and 30 day mortality ‐ Colorectal cancer · Patients with outcomes after colorectal cancer surgery
The intervention may leads to lower inpatient and 30 day mortality ‐ Colorectal cancer (low certainty).
1 finding from 1 review
Intervention not reported
Inpatient and 30 day mortality ‐ Colorectal cancer · Patients with outcomes after colorectal cancer surgery
It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Colorectal cancer (very low certainty).
1 finding from 1 review